Frontier
Copyright ©The Author(s) 2021.
World J Gastroenterol. Oct 28, 2021; 27(40): 6737-6749
Published online Oct 28, 2021. doi: 10.3748/wjg.v27.i40.6737
Figure 1
Figure 1 Factors involved in increasing or decreasing hepatocellular carcinoma risk, either before or after sustained virologic response. EV: Esophageal varices; VB: Variceal bleeding; ACLF: Acute on chronic liver failure; PH: Portal hypertension; SVR: Sustained virologic response; HCC: Hepatocellular carcinoma; MAFLD: Metabolic associated fatty liver disease.